Literature DB >> 17336764

Risk factors for schizophrenia--all roads lead to dopamine.

Marta Di Forti1, Julia M Lappin, Robin M Murray.   

Abstract

Schizophrenia is a debilitating disease of major public health importance, the incidence of which shows prominent worldwide variation (up to fivefold) and is about 40% greater in men than in women. Furthermore, epidemiological studies have shown that the incidence is higher among those who grow up in urban areas and among migrants. Recent evidence indicates that, although the neurochemical origins of schizophrenia do not necessarily lie in dopamine dysregulation, this operates as the final common pathway underlying positive psychotic symptoms and may also play a role in negative and cognitive symptoms. The last few years have seen the development of a plausible model in which schizophrenia is seen as the consequence of the actions of a number of component causes, such as genes or early environmental hazards that subtly alter subsequent neurodevelopment, thereby predisposing the child to later dopamine dysregulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336764     DOI: 10.1016/j.euroneuro.2007.02.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  37 in total

1.  Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia.

Authors:  James M Gold; Britta Hahn; Wei Wei Zhang; Benjamin M Robinson; Emily S Kappenman; Valerie M Beck; Steven J Luck
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

3.  A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.

Authors:  Peter D Alexander; Kristina M Gicas; Alex Cheng; Donna J Lang; Ric M Procyshyn; Alexandra T Vertinsky; William J Panenka; Allen E Thornton; Alexander Rauscher; Jamie Y X Wong; Tasha Chan; Andrea A Jones; F Vila-Rodriguez; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2019-06-22       Impact factor: 4.530

Review 4.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  Integrated Post-GWAS Analysis Sheds New Light on the Disease Mechanisms of Schizophrenia.

Authors:  Jhih-Rong Lin; Ying Cai; Quanwei Zhang; Wen Zhang; Rubén Nogales-Cadenas; Zhengdong D Zhang
Journal:  Genetics       Date:  2016-10-17       Impact factor: 4.562

Review 6.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

7.  Associations between psychotic-like symptoms and inattention/hyperactivity symptoms.

Authors:  Tuula Marketta Hurtig; Anja Taanila; Juha Veijola; Hanna Ebeling; Pirjo Mäki; Jouko Miettunen; Marika Kaakinen; Matti Joukamaa; Sebastian Therman; Markus Heinimaa; Marjo-Riitta Järvelin; Irma Moilanen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-12       Impact factor: 4.328

Review 8.  New atypical antipsychotics for schizophrenia: iloperidone.

Authors:  Silvio Caccia; Luca Pasina; Alessandro Nobili
Journal:  Drug Des Devel Ther       Date:  2010-02-18       Impact factor: 4.162

Review 9.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

Review 10.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.